Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Derm CasesDermatology / Internal Medicine

Derm Cases · Dermatology / Internal Medicine

OSCE — pruritus without primary rash: systemic work-up and targeted management

An 8-minute OSCE station on evaluating generalised itch with minimal primary skin findings, prioritising systemic causes (cholestasis, uraemia, iron deficiency, polycythaemia, lymphoma, drugs), and choosing cause-directed therapy over endless antihistamines.

8 minosce1 min readVerification in progress

Target exams

NEET-PGINICETUSMLEPLABMRCP
On this page
Study tools

Target exams

NEET-PGINICETUSMLEPLABMRCP
Prompt
An 8-minute OSCE station on evaluating generalised itch with minimal primary skin findings, prioritising systemic causes (cholestasis, uraemia, iron deficiency, polycythaemia, lymphoma, drugs), and choosing cause-directed therapy over endless antihistamines.

Brief (to candidate)

A 58-year-old has severe generalised itch for 3 months with only excoriations. No primary eczematous plaques. He takes multiple drugs; exam shows no jaundice yet. You have 8 minutes to take a focused history, plan investigations, and outline initial management.

Candidate instructions

  1. Define pruritus sine materia / itch without primary rash vs secondary excoriations.
  2. Screen systemic causes with history and first-line labs.
  3. Recognise polycythaemia vera and haematologic red flags (aquagenic itch).
  4. Avoid defaulting solely to sedating antihistamines.
  5. Give skin barrier care plus cause-directed therapy principles.
[6]

Examiner checklist (mark each domain / 10)

DomainKey actions expected
Clinical frameGeneralised itch with only secondary changes (excoriations, prurigo nodules) demands systemic review, not only dermatitic treatment
Key causesCholestasis (including pregnancy ICP context elsewhere), chronic kidney disease/uraemia, iron deficiency, thyroid disease, polycythaemia vera (aquagenic itch), Hodgkin lymphoma, HIV, drugs, occult infestation if subtle burrows missed, psychogenic after organic screen
History pearlsAquagenic itch → consider PV; nocturnal + contacts → scabies re-check; drug timeline; B symptoms; travel; wash practices
First-line work-upFBC (and film if indicated), ferritin/iron studies, U&E, LFT ± bilirubin/bile acids if cholestasis suspected, glucose/TFT; consider CXR/further haematology if red flags; age-appropriate malignancy review when indicated[1][2]
Skin careEmollients, soap substitutes, short cool baths, treat secondary infection/nodules; non-sedating antihistamines limited benefit if non-histaminergic
Cause-directedOptimise dialysis/uraemic care; treat iron deficiency; haematology referral for PV; cholestatic pathways; gabapentinoid consideration in uraemic itch under guidance[1][3]
Red flagsWeight loss, night sweats, lymphadenopathy, progressive jaundice, abnormal blood counts

Model key actions

  • Treat itch without primary rash as a systemic symptom complex and order core labs.[2]
  • Ask specifically for aquagenic itch and pursue polycythaemia when suggested.[1]
  • Combine emollient care with cause-directed therapy rather than endless sedating antihistamines alone.[3]

Common errors

  • Diagnosing “eczema” without primary lesions and giving only steroids.
  • Missing scabies by not re-examining finger webs/genitalia.
  • Ignoring FBC abnormalities / aquagenic itch.
  • Chronic first-generation antihistamines as sole plan.
  • No safety-net for B symptoms/malignancy.
[1] [2] [3]
References6ShowHide
  1. [1]Tefferi A, Barbui T. Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management. American Journal of Hematology, 2023.PMID 37357958
  2. [2]Butler DC, Berger T, Elmariah S, et al. Chronic Pruritus: A Review. JAMA, 2024.PMID 38809527
  3. [3]Sunderkötter C, Wohlrab J, Hamm H. Scabies: Epidemiology, Diagnosis, and Treatment. Deutsches Arzteblatt international, 2021.PMID 34615594
  4. [4]Borda LJ, Perper M, Keri JE. Treatment of seborrheic dermatitis: a comprehensive review. The Journal of dermatological treatment, 2019.PMID 29737895
  5. [5]Geisler AN, Phillips GS, Barrios DM, et al. Immune checkpoint inhibitor-related dermatologic adverse events. Journal of the American Academy of Dermatology, 2020.PMID 32454097
  6. [6]Mayo MJ, Carey E, Smith HT, et al. Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis Dig Dis Sci, 2023.PMID 35704252
PreviousOSCE — prescribe topical calcineurin inhibitors: face/fold use, proactive therapy, and safety counsellingDermatology / Therapeutics / PaediatricsNextOSCE — psychodermatology: delusional infestation, dermatitis artefacta, and skin-picking disordersDermatology / Psychiatry / Liaison